article Open AccessTop 1% cited
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
Arthritis & Rheumatism · 2011 · Vol. 63(3) · pp. 573–586
David T. Felson✉(Boston University)Josef S Smolen(Klinik Hietzing)George A. Wells(University of Ottawa)Yuqing Zhang(Vrije Universiteit Amsterdam)L. van Tuyl(Vrije Universiteit Amsterdam)Julia Funovits(Medical University of Vienna)Daniel Aletaha(Medical University of Vienna)Cornelia F Allaart(Leiden University)Joan M. Bathon(Johns Hopkins University)С. Бонини(University of Pisa)Peter Brooks(The University of Melbourne)Andrew Brown(University of York)Marco Matucci‐Cerinic(Florence (Netherlands))Hyon K. Choi(University of Ottawa)Bernard Combe(Université de Montpellier)Maarten de Wit(Sint Maartenskliniek)Maxime Dougados(Délégation Paris 5)Paul Emery(University of Leeds)Daniel E. Furst(University of California, Los Angeles)Juan J. Gómez‐Reino(Universidade de Santiago de Compostela)Gillian Hawker(University of Toronto)Edward Keystone(University of Toronto)Dinesh Khanna(University of California, Los Angeles)John Kirwan(University of Bristol)Tore K Kvien(Maastricht University)Robert Landewé(Maastricht University Medical Centre)Joachim ListingKaleb Michaud(The National Databank for Rheumatic Diseases)E. Martín‐Mola(Hospital Universitario La Paz)Pamela MontieTheodore Pincus(Supélec)Patricia Richards(At Bristol)Jeffrey N. Siegel(United States Food and Drug Administration)Lee S. SimonTuulikki Sokka(Central Finland Health Care District)Vibeke Strand(Palo Alto University)Peter Tugwell(University of Ottawa)Alan Tyndall(University of Basel)Desirée van der Heijde(Leiden University)Suzanne Verstappen(University of Manchester)Barbara WhiteFrederick Wolfe(University of Kansas)A. ZinkMaarten Boers(Vrije Universiteit Amsterdam)
Abstract
We propose two new definitions of remission, both of which can be uniformly applied and widely used in RA clinical trials. We recommend that one of these be selected as an outcome measure in each trial and that the results on both be reported for each trial.
Rheumatoid Arthritis Research and TherapiesMusculoskeletal Disorders and RehabilitationBiosimilars and Bioanalytical MethodsRheumatismMedicineRheumatologyRheumatoid arthritisClinical trialInternal medicinePhysical therapyLeagueFamily medicine
MeSH terms
Arthritis, RheumatoidClinical Trials as TopicData CollectionEuropeHumansTerminology as TopicPrognosisRemission InductionSeverity of Illness IndexUnited StatesTreatment OutcomeAntirheumatic AgentsEndpoint Determination
Funding
- Amgen
Citations
1,015
FWCI
58.90
field-weighted impact
References
71
Percentile
100%
vs. same field & year
Citations per year
Cited by
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Annals of the Rheumatic Diseases · 2015 · 1,431 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases · 2017 · 5,757 citations
References
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
Arthritis & Rheumatism · 2003 · 1,756 citations
Measurement of patient outcome in arthritis
Arthritis & Rheumatism · 1980 · 4,364 citations
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Arthritis & Rheumatism · 2005 · 1,780 citations
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial
Arthritis & Rheumatism · 2004 · 1,168 citations
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
Arthritis & Rheumatism · 1995 · 6,175 citations
REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE DISEASE ACTIVITY SCORE
Lara D. Veeken · 1995 · 376 citations
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
Annals of the Rheumatic Diseases · 2008 · 1,104 citations
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
Lara D. Veeken · 2003 · 1,048 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.